FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308382078> ?p ?o ?g. }

• W4308382078 abstract "<h3>Background</h3> T cell engagers (TCEs) activate T cells by bridging the CD3 complex to a tumor associated antigen (TAA). TCEs have shown clinical efficacy for hematological malignancies and hold promise for solid-tumors. Dose limiting toxicities, including Cytokine Release Syndrome (CRS) and Tumor Lysis Syndrome (TLS) remain major concerns. <h3>Methods</h3> We engineered two ROR1 specific TCEs with properties to increase the size of their therapeutic windows using a unique ROR1 specific VHH from Camelus bactrianus (clone 5A1) that contains a non-canonical disulfide-bond between CDR1 and CDR3 and ROR1 specific valency that (1) decouples cytotoxicity from cytokine release and (2) facilitates the discrimination between ROR1 cell surface density on normal versus tumor cells. <h3>Results</h3> When 5A1 was paired with an anti-CD3 Fab in two orientations that include a half-life extending Fc domain, we were able to establish a T cell/tumor synapse that resulted in sufficient activation to induce degranulation/tumor-killing at TCE concentrations of 10-30 pM (EC50 ~ 150-200 nM). In contrast, expression of CD69, CD25 and IFNg, the latter of which is directly upstream of CRS, was not observed until the concentration of TCEs reached ~1 nM (EC50 ~ 5-10 nM). Compared to the non-decoupling control TCE, 5A1 TCEs demonstrated 3.5-4.5 fold greater decoupling. In the context of JeKo1 CD19+/ROR1+ tumor targets, the 5A1 TCEs were 6-7.5 fold better decoupled compared to blinatumomab. We also observed an EC50-cytotoxicity for blinatumomab of below 100 fM, suggesting that the risk of both CRS and TLS are multiple folds higher than for 5A1 TCEs. Compared to the non-decoupling control TCE, the 5A1 TCEs mediated superior cytotoxicity/serial killing at an effector to target ratio (E:T) as low as 1:16, more consistent with solid-tumors. The 5A1 TCEs were also utilized ROR1 specific binding valency to discriminate between cell surface densities of ROR1 typical to tumor cells (>15k molecules/cell) versus normal cells (generally <10,000 molecules/cell). The concentration of TCEs required for maximum IFNg release and killing of tumor cells registered in the pM range, as opposed to the supraphysiologic nM/uM range that was insufficient to induce more than 25% and 35% of IFNg release and cytotoxicity, respectively, on cells expressing <10,000 molecules of ROR1. <h3>Conclusions</h3> We hypothesize, that our ROR1 TCEs will provide a superior therapeutic index and safety profile associated with reduced risks of CRS and TLS, the capacity to dose higher, avoid continuous infusion and potentially mediate better efficacy in solid tumors." @default.
• W4308382078 created "2022-11-11" @default.
• W4308382078 creator A5012957357 @default.
• W4308382078 creator A5026203504 @default.
• W4308382078 creator A5032457063 @default.
• W4308382078 creator A5045493438 @default.
• W4308382078 creator A5051736289 @default.
• W4308382078 creator A5057528246 @default.
• W4308382078 date "2022-11-01" @default.
• W4308382078 modified "2023-09-25" @default.
• W4308382078 title "1068 A ROR1 specific CD3 bispecific T-cell engager engineered for solid tumors with an expanded therapeutic window" @default.
• W4308382078 doi "https://doi.org/10.1136/jitc-2022-sitc2022.1068" @default.
• W4308382078 hasPublicationYear "2022" @default.
• W4308382078 type Work @default.
• W4308382078 citedByCount "0" @default.
• W4308382078 crossrefType "proceedings-article" @default.
• W4308382078 hasAuthorship W4308382078A5012957357 @default.
• W4308382078 hasAuthorship W4308382078A5026203504 @default.
• W4308382078 hasAuthorship W4308382078A5032457063 @default.
• W4308382078 hasAuthorship W4308382078A5045493438 @default.
• W4308382078 hasAuthorship W4308382078A5051736289 @default.
• W4308382078 hasAuthorship W4308382078A5057528246 @default.
• W4308382078 hasBestOaLocation W43083820781 @default.
• W4308382078 hasConcept C109316439 @default.
• W4308382078 hasConcept C147483822 @default.
• W4308382078 hasConcept C1491633281 @default.
• W4308382078 hasConcept C153911025 @default.
• W4308382078 hasConcept C167672396 @default.
• W4308382078 hasConcept C185592680 @default.
• W4308382078 hasConcept C19317047 @default.
• W4308382078 hasConcept C202751555 @default.
• W4308382078 hasConcept C203014093 @default.
• W4308382078 hasConcept C2776090121 @default.
• W4308382078 hasConcept C2778020697 @default.
• W4308382078 hasConcept C2778957590 @default.
• W4308382078 hasConcept C502942594 @default.
• W4308382078 hasConcept C55493867 @default.
• W4308382078 hasConcept C86803240 @default.
• W4308382078 hasConcept C8891405 @default.
• W4308382078 hasConcept C9756297 @default.
• W4308382078 hasConceptScore W4308382078C109316439 @default.
• W4308382078 hasConceptScore W4308382078C147483822 @default.
• W4308382078 hasConceptScore W4308382078C1491633281 @default.
• W4308382078 hasConceptScore W4308382078C153911025 @default.
• W4308382078 hasConceptScore W4308382078C167672396 @default.
• W4308382078 hasConceptScore W4308382078C185592680 @default.
• W4308382078 hasConceptScore W4308382078C19317047 @default.
• W4308382078 hasConceptScore W4308382078C202751555 @default.
• W4308382078 hasConceptScore W4308382078C203014093 @default.
• W4308382078 hasConceptScore W4308382078C2776090121 @default.
• W4308382078 hasConceptScore W4308382078C2778020697 @default.
• W4308382078 hasConceptScore W4308382078C2778957590 @default.
• W4308382078 hasConceptScore W4308382078C502942594 @default.
• W4308382078 hasConceptScore W4308382078C55493867 @default.
• W4308382078 hasConceptScore W4308382078C86803240 @default.
• W4308382078 hasConceptScore W4308382078C8891405 @default.
• W4308382078 hasConceptScore W4308382078C9756297 @default.
• W4308382078 hasLocation W43083820781 @default.
• W4308382078 hasOpenAccess W4308382078 @default.
• W4308382078 hasPrimaryLocation W43083820781 @default.
• W4308382078 hasRelatedWork W168235955 @default.
• W4308382078 hasRelatedWork W193432583 @default.
• W4308382078 hasRelatedWork W2001681139 @default.
• W4308382078 hasRelatedWork W2015847504 @default.
• W4308382078 hasRelatedWork W2015866042 @default.
• W4308382078 hasRelatedWork W2028968136 @default.
• W4308382078 hasRelatedWork W2031740266 @default.
• W4308382078 hasRelatedWork W2747317233 @default.
• W4308382078 hasRelatedWork W4313358904 @default.
• W4308382078 hasRelatedWork W4319880780 @default.
• W4308382078 isParatext "false" @default.
• W4308382078 isRetracted "false" @default.
• W4308382078 workType "article" @default.